CSIMarket
 


Quidelortho Corp  (QDEL)
Other Ticker:  
 


Quidelortho's Gross Profit Margin by quarter

Trends, Rankings, Statistics



QDEL Gross Profit Margin (Jul 03 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change 247.32 % 167.03 % -21.3 % 7.07 % -12.46 %
Seq. Revenue Change -38.8 % 57.37 % 24.94 % 188.62 % -52.95 %
Revenue In Millions $613.40 $1,002.26 $636.87 $509.74 $176.61
Gross Profit Margin 55.02 % 73.83 % 76.84 % 73.26 % 60.12 %
Gross Profit Margin Total Ranking # 2324 # 1576 # 1507 # 1595 # 2240
Gross Profit In Millions $337.50 $739.96 $489.34 $373.41 $106.19
Y / Y Gross Profit Change 217.84 % 145.05 % -30.24 % -2.66 % -28.61 %
Seq. Gross Profit Change -54.39 % 51.21 % 31.05 % 251.65 % -64.83 %


Commenting Second Quarter 2022 Gross Profit Margin
Quidelortho Corp experienced contraction in Gross Profit by -54.39 % to $613 millions and Revenue by -38.8 %, while Gross Profit Margin fell to 55.02 %, below company's average Gross Profit Margin.

Observing second quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 7 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from 1576 to 2324.
Learn about Gross Margin
QDEL's Gross Profit Margin second quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 8
Healthcare Sector # 503
Overall # 2325

Gross Profit Margin Statistics
High Average Low
86.69 % 63.05 % 47.01 %
(Dec 31 2020)   (Dec 31 2017)




Other Gross Profit Margin Profitability Ratios
QDEL's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
QDEL's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for QDEL's Competitors
Gross Profit Margin Profit Margin for Quidelortho's Suppliers
Gross Profit Margin Profit Margin for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Gross Profit Growth
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jul 03 2022, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginJul 03 2022 MRQ Gross ProfitJul 03 2022 MRQ Revenue
Intellia Therapeutics Inc.  100.00 %$ 14.030 $ 14.030 
Volitionrx Limited  100.00 %$ 0.040 $ 0.040 
Celldex Therapeutics inc.  100.00 %$ 0.163 $ 0.163 
Navidea Biopharmaceuticals Inc.  99.18 %$ 0.057 $ 0.058 
Myriad Genetics Inc.  72.28 %$ 129.600 $ 179.300 
Lantheus Holdings Inc.  61.70 %$ 138.029 $ 223.723 
Idexx Laboratories Inc  59.73 %$ 514.032 $ 860.546 
Quidelortho Corp  55.02 %$ 337.500 $ 613.400 
Meridian Bioscience Inc.  54.19 %$ 36.728 $ 67.771 
Aspira Women s Health Inc.  46.76 %$ 0.966 $ 2.066 
Neogen Corporation  46.40 %$ 64.999 $ 140.093 
Immucell Corp  44.22 %$ 1.707 $ 3.861 
Heska Corporation  42.25 %$ 27.328 $ 64.677 
Lucira Health Inc.  30.57 %$ 7.992 $ 26.146 
Quotient Limited  30.57 %$ 2.694 $ 8.814 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SINT's Profile

Stock Price

SINT's Financials

Business Description

Fundamentals

Charts & Quotes

SINT's News

Suppliers

SINT's Competitors

Customers & Markets

Economic Indicators

SINT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071